Editor(s):

(1) Dr. Ana Cláudia Coelho, University of Trás-os-Montes and Alto Douro, Portugal.

Reviewers:

(1) Zebene Mekonnen Assefa, Wolkite University, Ethiopia.

(2) Ferguson Ayemere Ehimen, Lily Hospital, Nigeria.

Additional Reviewers:

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 7.5/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Zebene Mekonnen Assefa, Ethiopia) | File 1 | File 2

Stage 2 | Peer review report_2 (Ferguson Ayemere Ehimen, Nigeria) | File 1 | File 2

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Giuseppe Murdaca, Clinical Immunology Unit,University of Genoa, Italy.

Reviewers:

(1) Attapon Cheepsattayakorn, Western University and Chest Disease Center, Thailand.

(2) Ashira Hiruntrakul, Khon Kaen University, Thailand.

Additional Reviewers:

(1) Premalatha Paulsamy, King Khalid University, Saudi Arabia.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 7.5/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Attapon Cheepsattayakorn, Thailand) | File 1 | NA

Stage 2 | Peer review report_2 (Ashira Hiruntrakul, Thailand) | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. S. Srinivasa Rao, Assistant Professor, V. R. Siddhartha Engineering College , Vijayawada-520007 Andhra Pradesh, India.

Reviewers:

(1) Kamal Narayan Kalita, Gauhati University, India

(2) Nwakuya Maureen Tobechukwu, University of Port Harcourt, Nigeria

(3) Jorge Alberto Ure, Hospital “Jose T. Borda” , Argentina

Additional Reviewers:

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 5/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Kamal Narayan Kalita, India) | File 1 | NA

Stage 2 | Peer review report_2 (Nwakuya Maureen Tobechukwu, Nigeria) | File 1 | NA

Stage 2 | Peer review report_3 (Jorge Alberto Ure, Argentina) | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Giuseppe Murdaca, Clinical Immunology Unit, University of Genoa, Italy.

Reviewers:

(1) Jaime Perez, Pontificia Universidad Javeriana, Colombia.

(2) Brian Mark Churchill, Learna, India.

Additional Reviewers:

(1) Banson Barugahare, Busitema University, Uganda.

(2) Ajay Gandhi, S.P. Medical College, India.

(3) Obolo Olupitan E, The Federal University of Technology, Nigeria.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 5.5/10

Average Peer review marks at publication stage: 8.5/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Jaime Perez, Colombia) | File 1 | NA

Stage 2 | Peer review report_2 (Brian Mark Churchill, India) | File 1 | File 2

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Ayhan Goktepe, Professor, Selcuk Universitesi, Teknik Bilimler MYO, Turkey.

(2) Dr. Juan Carlos Troiano, Professor, School of Veterinary Medicine, University of Buenos Aires, Argentina.

Reviewers:

(1)  Muhamad R. Abdel Hameed, Assiut University, Egypt.

(2) Ahmed Abdel Ghafar Saleh, Mansoura University, Egypt.

Additional Reviewers:

(1)  B. Puvarajan, TANUVAS-VCRI Orathanadu, India.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 7.5/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Muhamad R. Abdel Hameed, Egypt) | File 1 | NA

Stage 2 | Peer review report_2 (Ahmed Abdel Ghafar Saleh, Egypt) | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Stage 3 | Journal Change | File 1 | NA

Stage 3 | Comment_Editor_2_v1 | File 1 | NA

Editor(s):

(1) Dr. Farzaneh Mohamadpour, University of Sistan and Baluchestan, Iran.

Reviewers:

(1) Ilknur Demir Karakılıç, Eskişehir City Hospital, Turkey.

(2) Sreelatha S, RGUHS, India.

Additional Reviewers:

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 8.5/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Ilknur Demir Karakılıç, Turkey) | File 1 | NA

Stage 2 | Peer review report_2 (Sreelatha S, India) | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Hab. Mariusz Cycon, Medical University of Silesia, Poland.

Reviewers:

(1) Li  Wang, Southwest Medical University, China.

(2) James M. O’Brien, Penn State College of Medicine, United States.

Additional Reviewers:

(1) Deepti Sharma, Amrita Institute of Medical Sciences, India.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 6.8/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Li Wang, China) | File 1 | NA

Stage 2 | Peer review report_2 (James M. O’Brien, United States) | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Koteshwara Mudigonda, Director of Novel Drug Delivery Systems, Propharmex Company, India.

Reviewers:

(1) Jontari Hutagalung, NIHRD-MOH, Indonesia.

(2) Nadia Maria Sposi, Center for Gender-Specific Medicine Istituto Superiore di Sanità, Italy.

 (3) Akwuebu Susanna Osiro, Rivers State University, Nigeria.

Additional Reviewers:

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 8/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Jontari Hutagalung, Indonesia) | File 1 | File 2

Stage 2 | Peer review report_2 (Nadia Maria Sposi, Italy) | File 1 | NA

Stage 2 | Peer review report_3 (Akwuebu Susanna Osiro, Nigeria) | File 1 | File 2

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Rafik Karaman , Professor, College of Pharmacy, Al-Quds University, Jerusalem, Palestine.

Reviewers:

(1) Hsuan-Hsiang Chen, National Taiwan University Hospital, Taiwan.

(2) SCL Chandravanshi, Shyam Shah Medical College, India.

Additional Reviewers:

(1) Sunil Kumar, Datta Meghe Institute of Medical Sciences (Deemed to be University), India.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 7.5/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Hsuan-Hsiang Chen, Taiwan) | File 1 | NA

Stage 2 | Peer review report_2 (SCL Chandravanshi, India) | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Vasudevan Mani, Associate Professor, College of Pharmacy, Qassim University, Buraidah, Kingdom of Saudi Arabia.

(2) Dr. Sung-Kun Kim, Northeastern State University, USA.

Reviewers:

(1) Sumbane GO, University of Limpopo, South Africa.

(2) Fatemeh Moghaddam, Zanjan University Medical of Sciences, Iran.

(3) Ebtsam Aly Omer Abou Hashish, Alexandria University, Egypt.

(4)  Mantji Juliah Modula, Gauteng College of Nursing, South Africa.

Additional Reviewers:

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 8.125/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Sumbane G, South Africa) | File 1 | NA

Stage 2 | Peer review report_2 (Fatemeh Moghaddam, Iran) | File 1 | File 2

Stage 2 | Peer review report_3 (Ebtsam Aly Omer Abou Hashish, Egypt) | File 1 | File 2

Stage 2 | Peer review report_4 (Mantji Juliah Modula, South Africa) | File 1 | NA

Stage 2 | Journal change | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Stage 3 | Comment_Editor_2_v1 | File 1 | NA